Legend Biotech Corp
Legend Biotech develops and commercializes cell and gene therapy solutions for the treatment of cancer.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Legend Biotech's stock with a target price of $80.82, indicating strong growth potential.
Financial Health
Legend Biotech is showing strong revenue, cash flow, and profit margins, indicating solid financial health.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring LEGN
Alternative Cancer Therapies Focus Shifts 2025
The FDA's new boxed warning for Johnson & Johnson and Legend Biotech's cancer drug highlights potential safety issues in CAR-T therapies. This could shift focus to companies developing alternative and potentially safer oncology treatments.
Published: October 13, 2025
Explore BasketNext-Gen Multiple Myeloma Treatments
Discover biotech companies at the forefront of revolutionary cancer treatments. These carefully selected stocks represent innovators developing cutting-edge immunotherapies for multiple myeloma, a common blood cancer with significant unmet medical needs.
Published: July 3, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Pipeline progress to watch
Clinical readouts and regulatory milestones can re‑rate the company; outcomes are binary and can cause sharp moves, so monitor data timelines closely.
Manufacturing and scale
Commercial success depends on manufacturing scale and cost control as CAR‑T therapies are complex to produce; capacity constraints can affect revenues and margins.
Partner and market access
Partnerships help with commercial reach and risk sharing, but revenues and royalties depend on market uptake and pricing — performance can vary by region.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals develops treatments for diseases including cystic fibrosis and cancer.
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals is a leading biotechnology company that develops and manufactures innovative medicines for serious medical conditions.
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics based on RNA interference (RNAi).
